Although relations between the FDA and the medical device industry are vastly improved, medtech faces another tough challenge: How to define 'value' in value-based healthcare scenarios, according to a panel at the MedTech Investing Conference in Minneapolis.
When it comes to policy issues, it was good news/bad news for attendees of the 2015 MedTech Investing Conference in Minneapolis.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FRX9PP
Cap comentari:
Publica un comentari a l'entrada